Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 856 AL 870

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin

Hamuro A, Saito S.

Psychogeriatrics. 2010 Dec;10(4):198-200. doi: 10.1111/j.1479-8301.2010.00338.x.

Overview of non-pharmacological intervention for dementia and principles of brain-activating rehabilitation

Yamaguchi H, Maki Y, Yamagami T.

Psychogeriatrics. 2010 Dec;10(4):206-13. doi: 10.1111/j.1479-8301.2010.00323.x. Epub 2010 Aug 28.

Proton magnetic resonance spectroscopy in Alzheimer's disease, a review

Loos C, Achten E, Santens P.

Acta Neurol Belg. 2010 Dec;110(4):291-8.

Challenges of High-resolution Diffusion Imaging of the Human Medial Temporal Lobe in Alzheimer Disease

Zeineh MM, Holdsworth S, Skare S, Atlas SW, Bammer R.

Top Magn Reson Imaging. 2010 Dec;21(6):355-65. doi: 10.1097/RMR.0b013e31823f6413.

Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration

Okazaki K, Fu YJ, Nishihira Y, Endo M, Fukushima T, Ikeuchi T, Okamoto K, Onodera O, Nishizawa M, Takahashi H.

Neuropathology. 2010 Apr;30(2):140-8. doi: 10.1111/j.1440-1789.2009.01062.x. Epub 2009 Sep 22.

Evaluation of dementia rating scales in Parkinson's disease dementia

Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):142-8. doi: 10.1177/1533317509333904. Epub 2009 Apr 9.

Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases

Devi L, Anandatheerthavarada HK.

Biochim Biophys Acta. 2010 Jan;1802(1):11-9. doi: 10.1016/j.bbadis.2009.07.007. Epub 2009 Jul 18.

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S.

Int J Geriatr Psychiatry. 2010 Apr;25(4):419-26. doi: 10.1002/gps.2355.

Targeting Abeta and tau in Alzheimer's disease, an early interim report

Golde TE, Petrucelli L, Lewis J.

Exp Neurol. 2010 Jun;223(2):252-66. doi: 10.1016/j.expneurol.2009.07.035. Epub 2009 Aug 27.

Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation

Martikainen P, Pikkarainen M, Pöntynen K, Hiltunen M, Lehtovirta M, Tuisku S, Soininen H, Alafuzoff I.

Neuropathol Appl Neurobiol. 2010 Feb;36(1):41-54. doi: 10.1111/j.1365-2990.2009.01046.x. Epub 2009 Oct 22.

A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevance for Alzheimer's disease

Agnati LF, Guidolin D, Baluska F, Leo G, Barlow PW, Carone C, Genedani S.

Curr Alzheimer Res. 2010 Jun;7(4):307-22. doi: 10.2174/156720510791162395.

Transgenic Drosophila models of Alzheimer's disease and tauopathies

Iijima-Ando K, Iijima K.

Brain Struct Funct. 2010 Mar;214(2-3):245-62. doi: 10.1007/s00429-009-0234-4. Epub 2009 Dec 5.

Optical coherence tomography of the retina: applications in neurology

Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT.

Curr Opin Neurol. 2010 Feb;23(1):16-23. doi: 10.1097/WCO.0b013e328334e99b.

Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia

Darreh-Shori T, Jelic V.

Expert Opin Drug Saf. 2010 Jan;9(1):167-76. doi: 10.1517/14740330903439717.

Targeted hydrolysis of Beta-amyloid with engineered antibody fragment

Kasturirangan S, Sierks M.

Curr Alzheimer Res. 2010 May;7(3):214-22. doi: 10.2174/156720510791050876.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias